Newsbenzinga
Filana Therapeutics Sees H2 2026 Net Cash Used In Operations Of $11M-$15M; Year-End Cash $38M-$42M
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…